Both in Pharmaceuticals
Ernexa Therapeutics vs GRI Bio
Over the past year ERNA returned −95.3% and GRI returned −96.9%; their daily moves had a correlation of -0.03.
ERNA −95.3% GRI −96.9%Growth of $1, one year, split-adjusted
| Metric | ERNA | GRI |
|---|---|---|
| Price | $1.99 | $1.43 |
| Market cap | $2.3M | $3.1M |
| Today | −1.49% | −7.14% |
| 1 month | −11.0% | −24.7% |
| 6 months | −67.1% | −39.4% |
| Year to date | −93.4% | −79.3% |
| 1 year | −95.2% | −96.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $5.0M | $10.9M |
| Dividend yield | — | — |
| Volatility (60d) | 78.2% | 120.8% |
| Short % of float | 2.1% | 3.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).